“…Considerable clinical and laboratory evidence has demonstrated a combined deficiency of cell-mediated and humoral immunity in patients with Down syndrome (DS) [2,3,5,8,9,11,15,16,20,21,32,35,46,55,58,61,62,64]. In particular, abnormalities of cell-mediated immunity include morphological alterations of the thymus, decreased T-lymphocyte number and responses to mitogens and antigens as well as depressed activity of different thymus-dependent hormonal-like activities [4,10,13,17,22,29,33,34,43,49].…”